Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection (Q42984502)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2009

edit

Language	Label	Description	Also known as
English	Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection	scientific article published on December 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

title

Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

main subject

hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Hesham M Elgouhari

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

Claudia O Zein

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

Ibrahim Hanouneh

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

Ariel E Feldstein

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

Nizar N Zein

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

publication date

1 December 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

published in

Digestive Diseases and Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

volume

54

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

page(s)

2699-2705

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

cites work

Insulin resistance and hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10620-008-0683-2

retrieved

21 January 2018

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New classification and diagnostic criteria for diabetes mellitus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus infection in African Americans

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of obesity on treatment of chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of fibrosis in chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine network in nonresponding chronic hepatitis C patients with genotype 1: role of triple therapy with interferon alpha, ribavirin, and ursodeoxycholate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus reduces the therapeutic effectiveness of interferon-alpha2b plus ribavirin therapy in patients with chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis. An update on terminology and reporting.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of diabetes mellitus and chronic hepatitis C virus infection.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fibrogenic impact of high serum glucose in chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum concentration of gammaGT is a surrogate marker of hepatic TNF-alpha mRNA expression in chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19148751

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10620-008-0683-2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

PubMed publication ID

19148751

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19148751

retrieved

12 November 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42984502&oldid=2205728178"